Abstract
A hypoxanthine-aminopterin-thymidine (HAT) sensitive human fusion partner cell line, HK-128 was established from a human plasmacytoma line, LICR-LON-HMy2 (HMy2). The HK-128 cells showed a 100% cloning efficiency. Fusion efficiency of HK-128 was so high that one hybridoma cell was produced by fusion of 105 cells of HK-128 with lymphocytes, obtained from lymph nodes of breast cancer patients. About 90% of the resulted hybridomas were IgG producers. The remainder revealed IgM producing activity, which was lost by long term culture. This result indicates that the HK-128 cell line has an advantage for making hybridoma cells producing IgG. Among ca. 7,000 hybridomas obtained by fusion of HK-128 with lymphocytes of a breast cancer patient, we could establish a hybridoma cell line which produced IgG specifically reacting to a human breast cancer cell line, MCF-7.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aihara K, Yamada K, Murakami H, Nomura Y and Omura H (1988) Production of human-human hybridomas secreting monoclonal antibodies reactive to breast cancer cell lines. In Vitro Cell. Develop. Biol. 24: 959–962.
Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. (Suppl.) 97: 77–87.
Clark SA, James SE and Fitchett M (1988) A new parental cell line for human-human hybridoma production. Cytotechnology 1: 359–363.
Croce CM, Linnenbach A, Hall W, Steplewski Z and Koprowski H (1980) Production of human hybridomas secreting antibodies to measles virus. Nature 288: 488–489.
Douillard JY and Hoffman T (1983) Enzyme-linked immunosorbent assay for screening monoclonal antibody production using enzyme labeled second antibody. Methods in Enzymology 92: 168–174. Academic Press, Inc.
Glassy MC, Handley HH, Hagiwara H and Royston I (1983) UC729–6, a human lymphoblastoid B-cell line useful for generating antibodies-secreting human-human hybridomas. Proc. Natl. Acad. Sci. USA 80: 6327–6331.
Hashizume S, Murakami H, Kamei M, Hirose S, Shirai T, Yamada K and Omura H (1987) Specificity of anti-poly-nucleotide monoclonal antibodies from human-human hybridomas. In Vitro Cell. Develop. Biol. 23: 53–56.
Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37: 614–636.
Hojo H (1977) Establishment of cultured cell lines of human stomach cancer origin and their morphological characteristics. (In Japanese) Niigata Med. J. 91: 737–752.
Kuga N, Yoshida K, Seido T, Oboshi S, Koide T, Shimosato Y and Nomura T (1975) Heterotransplantation of cultured human cancer cells and human cancer tissues into nude mice. Gann 66: 547–560.
Murakami H, Hashizume S, Ohashi H, Shinohara K, Yasumoto K, Nomoto K and Omura H (1985) Human-human hybridoma secreting antibodies specific to human lung carcinoma. In Vitro Cell. Develop. Biol. 21: 593–596.
Murakami H (1989) Serum-free media used for cultivation of hybridomas. Monoclonal Antibodies: Production and Application, pp. 107–141. Alan R. Liss, Inc.
O'Hare MJ, Smith CM and Edwards PAW (1982) A new human hybridoma system (LICR-LON-HMy2) and its use in the production of human monoclonal antibodies. In: Peeters H (ed). Protides of Biological Fluids. Colloquium 30, pp. 265–268. Pergamon Press, Oxford.
Ohashi H, Hashizume S, Murakami H, Aihara K, Shinohara K and Omura H (1986) HO-323, A human B-lymphoblastoid cell line useful for making human-human hybridomas. Cell Biol. Int. Rep. 10: 77–83.
Olsson L and Kaplan HS (1980) Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc. Natl. Acad. Sci. USA 77: 5429–5431.
Soule AD, Vazquez J, Long A, Albert S and Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51: 1409–1416.
Thomas BK, Birgitte BR, Carsten R and Jesper Z (1988) Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients. Cancer Res. 48: 3208–3214.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kawahara, H., Yamada, K., Shirahata, S. et al. A new human fusion partner, HK-128, for making human-human hybridomas producing monoclonal IgG antibodies. Cytotechnology 4, 139–143 (1990). https://doi.org/10.1007/BF00365094
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00365094